An apolipoprotein E variant may protect against
age-related macular degeneration through cytokine regulation.
In a 2013 study, patients with early/mild
age-related macular degeneration were supplemented once- or twice-daily with lutein, zeaxanthin, low-dose omega-3s (100 mg DHA, 30 mg EPA), and antioxidant nutrients for one year.
Some of the key companies operating in the global
age-related macular degeneration market include Novartis AG, F.
Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in
age-related macular degeneration partnering since 2009, including a summary of deals by industry sector, stage of development, deal type, and technology type.
10) A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for
age-related macular degeneration and vision loss: AREDS report no.
New Treatments for
Age-Related Macular Degeneration.
This is an exciting study, because for people at high risk for developing advanced
age-related macular degeneration these nutrients are the first effective treatment to slow the progression of the disease," says NEI director Paul Sieving.
have announced an exclusive, worldwide license of an investigational therapy for the treatment of the wet form of
Age-Related Macular Degeneration (AMD), the most common cause of adult-onset blindness, and Diabetic Retinopathy.
com/research/t2mskf/global) has announced the addition of the "Global
Age-Related Macular Degeneration Epidemiology and Patient Flow Analysis - 2012" report to their offering.
The two leading causes of blindness are
age-related macular degeneration and cataract formation.
CLBS) has received a grant from the National Eye Institute of the National Institutes of Health to investigate 3D retinal constructs for vision restoration in patients with
age-related macular degeneration.
Age-Related Macular Degeneration, 2nd Edition (online access included)